当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析

国邦医药

(605507)

  

流通市值:70.36亿  总市值:130.32亿
流通股本:3.02亿   总股本:5.59亿

国邦医药(605507)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.68亿元,每股收益1.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益827527.54万元,未分配利润400352.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1057938.28万元,负债230410.75万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,469,884,398.263,026,283,783.221,440,055,937.135,890,839,205.64
营业总成本3,740,282,795.292,520,305,808.061,209,046,358.945,007,120,720.06
其他经营收益
营业利润779,438,726522,095,865.12248,478,156.59895,067,447.8
利润总额774,877,685.03521,309,059.35248,828,597.45887,969,784.1
净利润667,887,425.77453,993,510.87214,259,675.01780,577,499.03
每股收益
其他综合收益----
综合收益总额667,887,425.77453,993,510.87214,259,675.01780,577,499.03
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,752,197,720.145,987,061,299.826,261,211,433.945,874,299,808.13
非流动资产:
非流动资产合计4,827,185,118.834,821,031,333.44,853,472,522.64,906,136,359.45
资产总计10,579,382,838.9710,808,092,633.2211,114,683,956.5410,780,436,167.58
流动负债:
流动负债合计1,796,077,779.642,208,722,440.652,492,043,797.772,557,787,418.17
非流动负债:
非流动负债合计508,029,694.74537,988,742.88363,364,008.22170,591,500.78
负债合计2,304,107,474.382,746,711,183.532,855,407,805.992,728,378,918.95
所有者权益(或股东权益):
归属于母公司股东权益合计8,271,649,874.938,056,976,824.518,255,276,580.428,047,340,282.19
股东权益合计8,275,275,364.598,061,381,449.698,259,276,150.558,052,057,248.63
负债和股东权益合计10,579,382,838.9710,808,092,633.2211,114,683,956.5410,780,436,167.58
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,744,040,619.722,493,814,104.671,083,518,233.354,574,322,268.54
经营活动现金流出小计3,338,530,251.022,390,937,218.071,435,189,997.873,867,911,412.69
经营活动产生的现金流量净额405,510,368.7102,876,886.6-351,671,764.52706,410,855.85
投资活动产生的现金流量:
投资活动现金流入小计11,235,187,266.337,889,926,988.635,232,113,917.555,323,802,456.31
投资活动现金流出小计11,747,605,860.938,117,023,257.095,394,088,271.95,837,648,418.78
投资活动产生的现金流量净额-512,418,594.6-227,096,268.46-161,974,354.35-513,845,962.47
筹资活动产生的现金流量:
筹资活动现金流入小计912,045,385.23846,045,385.23560,269,185.23690,903,824.79
筹资活动现金流出小计1,187,167,685.771,088,149,639.28293,764,345.331,077,397,819.21
筹资活动产生的现金流量净额-275,122,300.54-242,104,254.05266,504,839.9-386,493,994.42
汇率变动对现金及现金等价物的影响3,233,366.234,476,304.155,105,660.3927,075,876.71
现金及现金等价物净增加额-378,797,160.21-361,847,331.76-242,035,618.58-166,853,224.33
期末现金及现金等价物余额1,155,574,403.631,172,524,232.081,292,335,945.261,534,371,563.84
补充资料:
现金及现金等价物的净增加额--361,847,331.76--166,853,224.33
最新报告期:2025-11-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券李梦园1.692.082.462025-11-09
开源证券阮帅,余汝意1.782.212.492025-10-20
西南证券徐卿1.882.232.522025-10-20
太平洋周豫,乔露阳1.712.042.352025-10-16
TOP↑